Literature DB >> 20501884

Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene.

Jaime Lin1, Eliete Chiconelli Faria, Antônio José Da Rocha, Marcelo Rodrigues Masruha, Luiz Celso Pereira Vilanova, Gert C Scheper, Marjo S Van der Knaap.   

Abstract

Leukoencephalopathy with brainstem and spinal cord involvement and elevated brain lactate diagnosis is based on its highly characteristic pattern of abnormalities observed by magnetic resonance imaging and spectroscopy. Clinically, affected patients develop slowly progressive cerebellar ataxia, spasticity, and dorsal column dysfunction, sometimes with a mild cognitive deficit or decline. In 2007, the pathophysiology of this disorder was elucidated with the discovery of mutations in the DARS2 gene, which encodes mitochondrial aspartyl-tRNA synthetase, in affected individuals. Here, the authors present a case of leukoencephalopathy with brainstem and spinal cord involvement with normal brain lactate, in which genetic analysis revealed a new mutation in the DARS2 gene not previously described.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501884     DOI: 10.1177/0883073810370897

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

Review 2.  Human aminoacyl-tRNA synthetases in diseases of the nervous system.

Authors:  Jana Ognjenović; Miljan Simonović
Journal:  RNA Biol       Date:  2017-06-30       Impact factor: 4.652

3.  Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene.

Authors:  Charalampos Tzoulis; Gia Tuong Tran; Ivar Otto Gjerde; Jan Aasly; Gesche Neckelmann; Jana Rydland; Viktoria Varga; Pia Wadel-Andersen; Laurence A Bindoff
Journal:  J Neurol       Date:  2011-07-27       Impact factor: 4.849

Review 4.  Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond.

Authors:  Angeles S Galindo-Feria; Antonella Notarnicola; Ingrid E Lundberg; Begum Horuluoglu
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

5.  Quantitative Proteomic Analysis of BHK-21 Cells Infected with Foot-and-Mouth Disease Virus Serotype Asia 1.

Authors:  Hui-Chen Guo; Ye Jin; Shi-Chong Han; Shi-Qi Sun; Yan-Quan Wei; Xian-Ji Liu; Xia Feng; Ding Xiang Liu; Xiang-Tao Liu
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

6.  Evolutionary and structural annotation of disease-associated mutations in human aminoacyl-tRNA synthetases.

Authors:  Manish Datt; Amit Sharma
Journal:  BMC Genomics       Date:  2014-12-04       Impact factor: 3.969

7.  Neurodegenerative disease-associated mutants of a human mitochondrial aminoacyl-tRNA synthetase present individual molecular signatures.

Authors:  Claude Sauter; Bernard Lorber; Agnès Gaudry; Loukmane Karim; Hagen Schwenzer; Frank Wien; Pierre Roblin; Catherine Florentz; Marie Sissler
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

8.  A novel DARS2 mutation in a Japanese patient with leukoencephalopathy with brainstem and spinal cord involvement but no lactate elevation.

Authors:  Keiko Shimojima; Takafumi Higashiguchi; Kanako Kishimoto; Satoko Miyatake; Noriko Miyake; Jun-Ichi Takanashi; Naomichi Matsumoto; Toshiyuki Yamamoto
Journal:  Hum Genome Var       Date:  2017-11-09

Review 9.  Aminoacyl-tRNA synthetases in medicine and disease.

Authors:  Peng Yao; Paul L Fox
Journal:  EMBO Mol Med       Date:  2013-02-21       Impact factor: 12.137

Review 10.  Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination.

Authors:  Amena Smith Fine; Christina L Nemeth; Miriam L Kaufman; Ali Fatemi
Journal:  J Neurodev Disord       Date:  2019-12-16       Impact factor: 4.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.